Cirujano General

Contents by Year, Volume and Issue

Table of Contents

General Information

Instructions for Authors

Message to Editor

Editorial Board

>Journals >Cirujano General >Year 2002, Issue 3

Gómez-Gómez E, Garduño-López AL, Mondragón-Sánchez R, Meneses-García A
Biliary cystadenocarcinoma and type I neurofibromatosis
Cir Gen 2002; 24 (3)

Language: Español
References: 12
Page: 221-224
PDF: 4. Kb.

Full text


Objective: To describe the case of a patient with type I neurofibromatosis that developed a biliary cystadenocarcinoma.
Setting: Third level health care hospital.
Design: Case report.
Description of the case: A woman, 59 years old, who presented abdominal pain in the epigastrium and right hypochondrium, and was diagnosed with a cystic mass in the left hepatic lobe. The biopsy, plus clinical data such as central and basal Lisch nodules, multiple, hyperpigmented, skin lesions, headache, vertigo, and neuralgia of the trigeminus led to the diagnosis of type I neurofibromatosis. Imaging studies (CAT) revealed a hypodense mass with semi-liquid features, of irregular borders, without metastases to intra-abdominal masses nor ganglionary growths. A laparotomy was performed, revealing two nodular cystic lesions of 3.9 x 3.7 and 3.5 x 2.7 cm, soft, with hemorrhagic zones and abundant gelatinous-aspect material. A left hepatectomy was performed (segments II, III, and IV) and the histopathologic study revealed a biliary cystadenoma. She received no adjuvant therapy, and 18 months later another CAT study revealed local tumor recurrence and pulmonary metastases.
Conclusion: Type I neurofibromatosis is an inherited disease, autosomically dominant, associated to malignant neoplasias such as biliary cystadenocarcinoma.

Key words: Type I neurofibromatosis, biliary cystoadenocarcinoma.


  1. Contran RS, Kumar V, Collins TR. Patología estructural y funcional. 6a ed. México: McGraw-Hill Interamericana; 2000.

  2. Hochberg FH, Dasilva AB, Galdabini J, Richardson EP Jr. Gastrointestinal involvement in von Recklinghausen’s neurofibromatosis. Neurology 1974; 24: 1144-51.

  3. Andreu V, Elizalde I, Mallafré C, Caballería J, Salmeron JM, Sans M, et al. Plexiform neurofibromatosis and angiosarcoma of the liver in von Recklinghausen´s disease. Am J Gastroenterology 1997; 92: 1229-30.

  4. Miyoshi LM, Tamiya S, Lida M, Hizawa K, Yao T, Tsuneyoshi M, et al. Primary jejunal malignant mixed tumor in a patient with von Recklinghause neurofibromatosis. Am J Gastroenterology 1996; 91: 795-7.

  5. Ishak KG, Willis GW, Cummins SD, Bullock AA. Biliary cistadenoma and cystadenocarcinoma: report of 14 cases and review of the literature. Cancer 1977; 39: 322-38.

  6. Choi BI, Lim JH, Han MC, Lee DH, Kim SH, Kim YI, et al. Biliary cistadenoma and cystadenocarcinoma: CT and sonographic findings. Radiology 1989; 171: 57-61.

  7. Takayasu K, Muramatsu Y, Moriyama N, Yamada T, Hasegawa H, Hirohashi S, et al. Imaging diagnosis of bile duct cystadenocarcinoma. Cancer 1988; 61: 941-6.

  8. Frameglia M, Nimura Y, Hayakawa N, Kamiya J, Kondo S, Nagido M, et al. Biliary cystadenocarcinoma resected by segment 3 and 4 hepatectomy. Hepato gastroenterology 1996; 43: 1029-34.

  9. Woods GL. Biliary cystadenocarcinoma: case report of hepatic malignancy originating in benign cistadenoma. Cancer 1981; 47: 2936-40.

  10. Kamamori H, Kawahara H, Oh S, Mine T, Osawa H, Murakami T, et al. A case of biliary cystadenocarcinoma with recurrent jaundice: diagnostic evaluation of computed tomography. Cancer 1985; 55: 2722-4.

  11. Devaney K, Goodman ZD, Ishak KG. Hepatobiliary cistadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients. Am J Surg Pathol 1994; 18: 1078-91.

  12. Hanazaki K, Yoshizawa K, Mori H. Hepatic arterial infusion chemotherapy of cisplatin for biliary cystadenocarcinoma. Hepatogastroenterology 1999; 46: 462-4.

>Journals >Cirujano General >Year 2002, Issue 3

· Journal Index 
· Links 

Copyright 2019